Kanya Rajangam
Präsident bei SENTI BIOSCIENCES, INC.
Vermögen: 28 179 $ am 30.04.2024
Aktive Positionen von Kanya Rajangam
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SENTI BIOSCIENCES, INC. | Präsident | 14.05.2024 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.07.2022 | 14.05.2024 | |
| TURNSTONE BIOLOGICS CORP. | Direktor/Vorstandsmitglied | 01.11.2021 | - |
| Independent Dir/Board Member | 01.11.2021 | - | |
Turnstone Biologics, Inc.
 Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Direktor/Vorstandsmitglied | 01.11.2011 | - |
| Independent Dir/Board Member | 01.11.2011 | - |
Karriereverlauf von Kanya Rajangam
Ehemalige bekannte Positionen von Kanya Rajangam
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NKARTA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2018 | 05.06.2022 |
| ATARA BIOTHERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2017 | 01.09.2018 |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 23.06.2015 | 01.07.2017 |
| NEKTAR THERAPEUTICS | Direktor/Vorstandsmitglied | 01.03.2015 | 01.05.2015 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2011 | 01.02.2015 |
| EXELIXIS, INC. | Corporate Officer/Principal | 01.01.2008 | 01.04.2011 |
Ausbildung von Kanya Rajangam
| Northwestern University | Doctorate Degree |
| St. John's Medical College | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 10 |
| 2 | |
| Kanada | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 5 |
| Director/Board Member | 3 |
| Doctorate Degree | 2 |
Sektoral
| Health Technology | 10 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| EXELIXIS, INC. | Health Technology |
| NKARTA, INC. | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| SENTI BIOSCIENCES, INC. | Health Technology |
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Turnstone Biologics, Inc.
Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Health Technology |
- Börse
- Insiders
- Kanya Rajangam
- Erfahrung
